Target intelligence / Profile preview

Ribosomal protein L34 pseudogene 11 (RPL34P11)

Target
RPL34P11
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L34 pseudogene 11 (RPL34P11) is a processed pseudogene—a non-functional genomic DNA sequence similar to the functional ribosomal protein L34 (RPL34) gene. Pseudogenes do not encode active proteins and are not considered functional molecular targets. RPL34P11 has been officially acknowledged by the HUGO Gene Nomenclature Committee as a pseudogene, not as a protein-coding or functional gene[6]. There is no evidence for protein product expression, biological function, or therapeutic relevance. Like other ribosomal protein pseudogenes, it is typically dispersed in the genome and lacks biological activity or disease association[3][6]. Key Notes: - RPL34P11 should not be confused with the functional ribosomal protein L34 (RPL34), which encodes a structural component of the 60S ribosomal subunit[1][2][3]. - This pseudogene is not a receptor, enzyme, transporter, or any type of classical druggable target. - There is no information linking RPL34P11 to any disease, biological function, or drug interaction in humans[3][6]. - The presence of "pseudogene" in the name indicates its non-coding, non-functional nature[6]. Summary: RPL34P11 is a non-functional processed pseudogene and is not considered a valid therapeutic target, nor does it have biological or clinical relevance.

Other names
RPL34P11RPL34_6_354

Beyond the preview

Go deeper on Ribosomal protein L34 pseudogene 11 (RPL34P11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L34 pseudogene 11 (RPL34P11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call